Supernus, Inc. (INDV) stock
INDVNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SUPN
$35.37+0.12 (+0.34%)
Close on Oct 30, 2026Market cap $4.17BP/E 9.9Yield –
Supernus operating margin
Operating margin is operating income as a percentage of revenue.
Supernus's operating margin for the twelve months ending Sep 30, 2026 was 40.6%. For fiscal 2025 it was 21.1%, against 3.2% the year before. The highest annual figure on record is 26.9% in fiscal 2021.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 21.1% | +17.9 |
| FY2024 | Dec 31, 2024 | 3.2% | +17.1 |
| FY2023 | Dec 31, 2023 | -13.9% | −5.4 |
| FY2022 | Dec 31, 2022 | -8.5% | −35.5 |
| FY2021 | Dec 31, 2021 | 26.9% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 50.6% | +36.9 |
| Q2 FY2026 | Jun 30, 2026 | 46.6% | +22.8 |
| Q1 FY2026 | Mar 31, 2026 | 43.2% | +18.4 |
| Q4 FY2025 | Dec 31, 2025 | 22.6% | +7.2 |
| Q3 FY2025 | Sep 30, 2025 | 13.7% | +2.3 |
| Q2 FY2025 | Jun 30, 2025 | 23.8% | +63.3 |
| Q1 FY2025 | Mar 31, 2025 | 24.8% | −1.6 |
| Q4 FY2024 | Dec 31, 2024 | 15.4% | – |
| Q3 FY2024 | Sep 30, 2024 | 11.4% | – |
| Q2 FY2024 | Jun 30, 2024 | -39.5% | – |
| Q1 FY2024 | Mar 31, 2024 | 26.4% | – |
See a number that looks wrong?